<DOC>
	<DOCNO>NCT00495183</DOCNO>
	<brief_summary>The aim study assess efficacy caffeine compare placebo maintenance treatment cocaine dependence . Caffeine potentiation biperiden also study . Ninety patient snorted/sniffed cocaine dependence randomize receive caffeine ( 300 - 1200 mg t.i.d . ) plus biperidene ( 8 mg b.i.d . ) caffeine ( 300 - 1200 mg t.i.d . ) placebo placebo 10 day in-hospital setting .</brief_summary>
	<brief_title>Efficacy Caffeine , With Without Biperiden , Maintenance Treatment Cocaine Dependence</brief_title>
	<detailed_description />
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Caffeine</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<mesh_term>Biperiden</mesh_term>
	<mesh_term>Biperiden lactate</mesh_term>
	<criteria>diagnosis cocaine dependence , accord DSMIVTR criterion age 18 60 year current cocaine use , confirm positive urine drug screen cocaine week prior admission . demonstrate capacity grant inform consent sign pertinent inform consent form . place residence compatible attendance center . woman , willingness use effective contraceptive measure study . diagnosis severe medical disorder could interfere study presence organic pathology methylxanthines biperidene administration contraindicate serum liver transaminase level 3 time higher normal value pregnancy breastfeed neuroleptic medication treatment past 6 week current treatment , anticipation patient may need initiate treatment study , drug may interact study medication . current diagnosis major mental disorder . awareness situation could prevent patient 's participation study ( e.g . serve sentence ) current participation another research project .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>cocaine dependence</keyword>
	<keyword>cocaine use</keyword>
	<keyword>CNS stimulant</keyword>
	<keyword>caffeine</keyword>
	<keyword>biperiden</keyword>
	<keyword>placebo</keyword>
</DOC>